{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.8","upperLimit":"46.4","value":"14.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"}],"units":"Participants"}],"description":"The median overall survival time is defined as the time from registration to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients receive oral 40 mg panobinostat 3 times weekly. Treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Arm I (LBH589)"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Every 6 months for up to 2 years","title":"Median Overall Survival Time","type":"SECONDARY","unitOfMeasure":"months"}